nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP3A4—Thiotepa—sarcoma	0.0781	0.458	CbGbCtD
Sitaxentan—CYP3A4—Mitoxantrone—sarcoma	0.0336	0.197	CbGbCtD
Sitaxentan—CYP3A4—Vincristine—sarcoma	0.0231	0.136	CbGbCtD
Sitaxentan—CYP3A4—Etoposide—sarcoma	0.0212	0.124	CbGbCtD
Sitaxentan—CYP3A4—Doxorubicin—sarcoma	0.0144	0.0847	CbGbCtD
Sitaxentan—EDNRB—mammary gland—sarcoma	0.0125	0.118	CbGeAlD
Sitaxentan—EDNRA—mammary gland—sarcoma	0.0103	0.0974	CbGeAlD
Sitaxentan—EDNRB—myometrium—sarcoma	0.00885	0.0836	CbGeAlD
Sitaxentan—EDNRA—myometrium—sarcoma	0.00732	0.0691	CbGeAlD
Sitaxentan—EDNRA—seminal vesicle—sarcoma	0.00661	0.0624	CbGeAlD
Sitaxentan—EDNRB—cardiac atrium—sarcoma	0.00577	0.0545	CbGeAlD
Sitaxentan—EDNRB—uterus—sarcoma	0.00574	0.0542	CbGeAlD
Sitaxentan—EDNRB—tendon—sarcoma	0.00503	0.0475	CbGeAlD
Sitaxentan—EDNRA—cardiac atrium—sarcoma	0.00477	0.0451	CbGeAlD
Sitaxentan—EDNRA—uterus—sarcoma	0.00474	0.0448	CbGeAlD
Sitaxentan—EDNRB—testis—sarcoma	0.00416	0.0393	CbGeAlD
Sitaxentan—EDNRA—tendon—sarcoma	0.00416	0.0393	CbGeAlD
Sitaxentan—EDNRB—liver—sarcoma	0.00394	0.0372	CbGeAlD
Sitaxentan—EDNRA—testis—sarcoma	0.00344	0.0325	CbGeAlD
Sitaxentan—CYP2C9—mammary gland—sarcoma	0.00341	0.0322	CbGeAlD
Sitaxentan—EDNRB—lymph node—sarcoma	0.00302	0.0285	CbGeAlD
Sitaxentan—CYP2C19—hematopoietic system—sarcoma	0.00268	0.0253	CbGeAlD
Sitaxentan—EDNRA—lymph node—sarcoma	0.00249	0.0236	CbGeAlD
Sitaxentan—CYP2C9—hematopoietic system—sarcoma	0.00208	0.0196	CbGeAlD
Sitaxentan—CYP3A4—hematopoietic system—sarcoma	0.00158	0.015	CbGeAlD
Sitaxentan—CYP2C19—liver—sarcoma	0.00139	0.0131	CbGeAlD
Sitaxentan—CYP2C9—liver—sarcoma	0.00108	0.0102	CbGeAlD
Sitaxentan—CYP3A4—liver—sarcoma	0.000821	0.00776	CbGeAlD
Sitaxentan—Liver function test abnormal—Epirubicin—sarcoma	0.000591	0.000817	CcSEcCtD
Sitaxentan—Dry skin—Epirubicin—sarcoma	0.000587	0.000811	CcSEcCtD
Sitaxentan—Decreased appetite—Mitoxantrone—sarcoma	0.000587	0.000811	CcSEcCtD
Sitaxentan—Chest pain—Etoposide—sarcoma	0.000586	0.000809	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Epirubicin—sarcoma	0.000585	0.000808	CcSEcCtD
Sitaxentan—Abdominal pain upper—Epirubicin—sarcoma	0.000585	0.000808	CcSEcCtD
Sitaxentan—Migraine—Doxorubicin—sarcoma	0.000583	0.000806	CcSEcCtD
Sitaxentan—Fatigue—Mitoxantrone—sarcoma	0.000582	0.000804	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000582	0.000804	CcSEcCtD
Sitaxentan—Discomfort—Etoposide—sarcoma	0.000579	0.000799	CcSEcCtD
Sitaxentan—Breast disorder—Epirubicin—sarcoma	0.000579	0.000799	CcSEcCtD
Sitaxentan—Constipation—Mitoxantrone—sarcoma	0.000577	0.000797	CcSEcCtD
Sitaxentan—Pain—Mitoxantrone—sarcoma	0.000577	0.000797	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000577	0.000797	CcSEcCtD
Sitaxentan—Hypersensitivity—Thiotepa—sarcoma	0.000576	0.000796	CcSEcCtD
Sitaxentan—Hypersensitivity—Dactinomycin—sarcoma	0.000571	0.00079	CcSEcCtD
Sitaxentan—Confusional state—Etoposide—sarcoma	0.000566	0.000782	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000565	0.00078	CcSEcCtD
Sitaxentan—Muscular weakness—Epirubicin—sarcoma	0.000565	0.00078	CcSEcCtD
Sitaxentan—Asthenia—Thiotepa—sarcoma	0.000561	0.000775	CcSEcCtD
Sitaxentan—Infection—Etoposide—sarcoma	0.000558	0.000771	CcSEcCtD
Sitaxentan—Ataxia—Doxorubicin—sarcoma	0.000557	0.00077	CcSEcCtD
Sitaxentan—Asthenia—Dactinomycin—sarcoma	0.000557	0.000769	CcSEcCtD
Sitaxentan—Feeling abnormal—Mitoxantrone—sarcoma	0.000556	0.000769	CcSEcCtD
Sitaxentan—Blood creatinine increased—Doxorubicin—sarcoma	0.000555	0.000767	CcSEcCtD
Sitaxentan—Asthma—Epirubicin—sarcoma	0.000553	0.000765	CcSEcCtD
Sitaxentan—Dehydration—Doxorubicin—sarcoma	0.000551	0.000761	CcSEcCtD
Sitaxentan—Thrombocytopenia—Etoposide—sarcoma	0.00055	0.00076	CcSEcCtD
Sitaxentan—Tachycardia—Etoposide—sarcoma	0.000548	0.000757	CcSEcCtD
Sitaxentan—Eosinophilia—Epirubicin—sarcoma	0.000548	0.000757	CcSEcCtD
Sitaxentan—Body temperature increased—Vincristine—sarcoma	0.000548	0.000757	CcSEcCtD
Sitaxentan—Liver function test abnormal—Doxorubicin—sarcoma	0.000547	0.000756	CcSEcCtD
Sitaxentan—Skin disorder—Etoposide—sarcoma	0.000545	0.000753	CcSEcCtD
Sitaxentan—Dry skin—Doxorubicin—sarcoma	0.000543	0.00075	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Doxorubicin—sarcoma	0.000541	0.000748	CcSEcCtD
Sitaxentan—Abdominal pain upper—Doxorubicin—sarcoma	0.000541	0.000748	CcSEcCtD
Sitaxentan—Angina pectoris—Epirubicin—sarcoma	0.000539	0.000745	CcSEcCtD
Sitaxentan—Urticaria—Mitoxantrone—sarcoma	0.000536	0.000741	CcSEcCtD
Sitaxentan—Breast disorder—Doxorubicin—sarcoma	0.000535	0.00074	CcSEcCtD
Sitaxentan—Anorexia—Etoposide—sarcoma	0.000535	0.000739	CcSEcCtD
Sitaxentan—Diarrhoea—Thiotepa—sarcoma	0.000535	0.000739	CcSEcCtD
Sitaxentan—Body temperature increased—Mitoxantrone—sarcoma	0.000534	0.000737	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000533	0.000737	CcSEcCtD
Sitaxentan—Bronchitis—Epirubicin—sarcoma	0.000532	0.000735	CcSEcCtD
Sitaxentan—Diarrhoea—Dactinomycin—sarcoma	0.000531	0.000733	CcSEcCtD
Sitaxentan—Pancytopenia—Epirubicin—sarcoma	0.000526	0.000726	CcSEcCtD
Sitaxentan—Hypotension—Etoposide—sarcoma	0.000525	0.000725	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000523	0.000722	CcSEcCtD
Sitaxentan—Muscular weakness—Doxorubicin—sarcoma	0.000523	0.000722	CcSEcCtD
Sitaxentan—Dysuria—Epirubicin—sarcoma	0.000517	0.000715	CcSEcCtD
Sitaxentan—Dizziness—Thiotepa—sarcoma	0.000517	0.000714	CcSEcCtD
Sitaxentan—Asthma—Doxorubicin—sarcoma	0.000512	0.000708	CcSEcCtD
Sitaxentan—Pollakiuria—Epirubicin—sarcoma	0.000511	0.000706	CcSEcCtD
Sitaxentan—Hypersensitivity—Vincristine—sarcoma	0.000511	0.000706	CcSEcCtD
Sitaxentan—Eosinophilia—Doxorubicin—sarcoma	0.000507	0.000701	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Epirubicin—sarcoma	0.000505	0.000698	CcSEcCtD
Sitaxentan—Weight decreased—Epirubicin—sarcoma	0.000501	0.000692	CcSEcCtD
Sitaxentan—Hyperglycaemia—Epirubicin—sarcoma	0.000499	0.00069	CcSEcCtD
Sitaxentan—Somnolence—Etoposide—sarcoma	0.000499	0.00069	CcSEcCtD
Sitaxentan—Angina pectoris—Doxorubicin—sarcoma	0.000499	0.000689	CcSEcCtD
Sitaxentan—Hypersensitivity—Mitoxantrone—sarcoma	0.000497	0.000687	CcSEcCtD
Sitaxentan—Asthenia—Vincristine—sarcoma	0.000497	0.000687	CcSEcCtD
Sitaxentan—Vomiting—Thiotepa—sarcoma	0.000497	0.000687	CcSEcCtD
Sitaxentan—Infestation NOS—Epirubicin—sarcoma	0.000493	0.000682	CcSEcCtD
Sitaxentan—Infestation—Epirubicin—sarcoma	0.000493	0.000682	CcSEcCtD
Sitaxentan—Vomiting—Dactinomycin—sarcoma	0.000493	0.000681	CcSEcCtD
Sitaxentan—Rash—Thiotepa—sarcoma	0.000493	0.000681	CcSEcCtD
Sitaxentan—Bronchitis—Doxorubicin—sarcoma	0.000492	0.00068	CcSEcCtD
Sitaxentan—Dermatitis—Thiotepa—sarcoma	0.000492	0.00068	CcSEcCtD
Sitaxentan—Headache—Thiotepa—sarcoma	0.00049	0.000677	CcSEcCtD
Sitaxentan—Rash—Dactinomycin—sarcoma	0.000489	0.000676	CcSEcCtD
Sitaxentan—Decreased appetite—Etoposide—sarcoma	0.000488	0.000674	CcSEcCtD
Sitaxentan—Pancytopenia—Doxorubicin—sarcoma	0.000486	0.000672	CcSEcCtD
Sitaxentan—Renal failure—Epirubicin—sarcoma	0.000485	0.00067	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Etoposide—sarcoma	0.000485	0.00067	CcSEcCtD
Sitaxentan—Asthenia—Mitoxantrone—sarcoma	0.000484	0.000669	CcSEcCtD
Sitaxentan—Fatigue—Etoposide—sarcoma	0.000484	0.000669	CcSEcCtD
Sitaxentan—Stomatitis—Epirubicin—sarcoma	0.000481	0.000665	CcSEcCtD
Sitaxentan—Jaundice—Epirubicin—sarcoma	0.000481	0.000665	CcSEcCtD
Sitaxentan—Pain—Etoposide—sarcoma	0.00048	0.000663	CcSEcCtD
Sitaxentan—Constipation—Etoposide—sarcoma	0.00048	0.000663	CcSEcCtD
Sitaxentan—Conjunctivitis—Epirubicin—sarcoma	0.00048	0.000663	CcSEcCtD
Sitaxentan—Dysuria—Doxorubicin—sarcoma	0.000479	0.000662	CcSEcCtD
Sitaxentan—Diarrhoea—Vincristine—sarcoma	0.000474	0.000655	CcSEcCtD
Sitaxentan—Pollakiuria—Doxorubicin—sarcoma	0.000473	0.000654	CcSEcCtD
Sitaxentan—Haematuria—Epirubicin—sarcoma	0.00047	0.00065	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Doxorubicin—sarcoma	0.000467	0.000646	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Epirubicin—sarcoma	0.000467	0.000645	CcSEcCtD
Sitaxentan—Epistaxis—Epirubicin—sarcoma	0.000465	0.000643	CcSEcCtD
Sitaxentan—Nausea—Thiotepa—sarcoma	0.000464	0.000641	CcSEcCtD
Sitaxentan—Weight decreased—Doxorubicin—sarcoma	0.000463	0.00064	CcSEcCtD
Sitaxentan—Sinusitis—Epirubicin—sarcoma	0.000463	0.00064	CcSEcCtD
Sitaxentan—Feeling abnormal—Etoposide—sarcoma	0.000463	0.000639	CcSEcCtD
Sitaxentan—Hyperglycaemia—Doxorubicin—sarcoma	0.000462	0.000638	CcSEcCtD
Sitaxentan—Diarrhoea—Mitoxantrone—sarcoma	0.000462	0.000638	CcSEcCtD
Sitaxentan—Nausea—Dactinomycin—sarcoma	0.000461	0.000637	CcSEcCtD
Sitaxentan—Dizziness—Vincristine—sarcoma	0.000458	0.000633	CcSEcCtD
Sitaxentan—Infestation—Doxorubicin—sarcoma	0.000457	0.000631	CcSEcCtD
Sitaxentan—Infestation NOS—Doxorubicin—sarcoma	0.000457	0.000631	CcSEcCtD
Sitaxentan—Bradycardia—Epirubicin—sarcoma	0.000451	0.000623	CcSEcCtD
Sitaxentan—Renal failure—Doxorubicin—sarcoma	0.000449	0.00062	CcSEcCtD
Sitaxentan—Urticaria—Etoposide—sarcoma	0.000446	0.000616	CcSEcCtD
Sitaxentan—Haemoglobin—Epirubicin—sarcoma	0.000445	0.000615	CcSEcCtD
Sitaxentan—Stomatitis—Doxorubicin—sarcoma	0.000445	0.000615	CcSEcCtD
Sitaxentan—Jaundice—Doxorubicin—sarcoma	0.000445	0.000615	CcSEcCtD
Sitaxentan—Rhinitis—Epirubicin—sarcoma	0.000444	0.000614	CcSEcCtD
Sitaxentan—Body temperature increased—Etoposide—sarcoma	0.000444	0.000613	CcSEcCtD
Sitaxentan—Conjunctivitis—Doxorubicin—sarcoma	0.000444	0.000613	CcSEcCtD
Sitaxentan—Hepatitis—Epirubicin—sarcoma	0.000443	0.000612	CcSEcCtD
Sitaxentan—Haemorrhage—Epirubicin—sarcoma	0.000443	0.000612	CcSEcCtD
Sitaxentan—Vomiting—Vincristine—sarcoma	0.000441	0.000609	CcSEcCtD
Sitaxentan—Urinary tract disorder—Epirubicin—sarcoma	0.000437	0.000604	CcSEcCtD
Sitaxentan—Rash—Vincristine—sarcoma	0.000437	0.000604	CcSEcCtD
Sitaxentan—Dermatitis—Vincristine—sarcoma	0.000437	0.000603	CcSEcCtD
Sitaxentan—Oedema peripheral—Epirubicin—sarcoma	0.000436	0.000603	CcSEcCtD
Sitaxentan—Haematuria—Doxorubicin—sarcoma	0.000435	0.000601	CcSEcCtD
Sitaxentan—Urethral disorder—Epirubicin—sarcoma	0.000434	0.0006	CcSEcCtD
Sitaxentan—Headache—Vincristine—sarcoma	0.000434	0.0006	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Doxorubicin—sarcoma	0.000432	0.000597	CcSEcCtD
Sitaxentan—Epistaxis—Doxorubicin—sarcoma	0.000431	0.000595	CcSEcCtD
Sitaxentan—Vomiting—Mitoxantrone—sarcoma	0.000429	0.000593	CcSEcCtD
Sitaxentan—Sinusitis—Doxorubicin—sarcoma	0.000428	0.000592	CcSEcCtD
Sitaxentan—Visual impairment—Epirubicin—sarcoma	0.000427	0.00059	CcSEcCtD
Sitaxentan—Rash—Mitoxantrone—sarcoma	0.000426	0.000588	CcSEcCtD
Sitaxentan—Dermatitis—Mitoxantrone—sarcoma	0.000425	0.000587	CcSEcCtD
Sitaxentan—Headache—Mitoxantrone—sarcoma	0.000423	0.000584	CcSEcCtD
Sitaxentan—Bradycardia—Doxorubicin—sarcoma	0.000417	0.000577	CcSEcCtD
Sitaxentan—Eye disorder—Epirubicin—sarcoma	0.000414	0.000572	CcSEcCtD
Sitaxentan—Hypersensitivity—Etoposide—sarcoma	0.000414	0.000572	CcSEcCtD
Sitaxentan—Tinnitus—Epirubicin—sarcoma	0.000413	0.000571	CcSEcCtD
Sitaxentan—Haemoglobin—Doxorubicin—sarcoma	0.000412	0.000569	CcSEcCtD
Sitaxentan—Nausea—Vincristine—sarcoma	0.000412	0.000569	CcSEcCtD
Sitaxentan—Flushing—Epirubicin—sarcoma	0.000411	0.000568	CcSEcCtD
Sitaxentan—Cardiac disorder—Epirubicin—sarcoma	0.000411	0.000568	CcSEcCtD
Sitaxentan—Rhinitis—Doxorubicin—sarcoma	0.000411	0.000568	CcSEcCtD
Sitaxentan—Haemorrhage—Doxorubicin—sarcoma	0.00041	0.000566	CcSEcCtD
Sitaxentan—Hepatitis—Doxorubicin—sarcoma	0.00041	0.000566	CcSEcCtD
Sitaxentan—Urinary tract disorder—Doxorubicin—sarcoma	0.000405	0.000559	CcSEcCtD
Sitaxentan—Oedema peripheral—Doxorubicin—sarcoma	0.000404	0.000558	CcSEcCtD
Sitaxentan—Asthenia—Etoposide—sarcoma	0.000403	0.000557	CcSEcCtD
Sitaxentan—Angiopathy—Epirubicin—sarcoma	0.000402	0.000555	CcSEcCtD
Sitaxentan—Urethral disorder—Doxorubicin—sarcoma	0.000402	0.000555	CcSEcCtD
Sitaxentan—Nausea—Mitoxantrone—sarcoma	0.000401	0.000554	CcSEcCtD
Sitaxentan—Immune system disorder—Epirubicin—sarcoma	0.0004	0.000553	CcSEcCtD
Sitaxentan—Mediastinal disorder—Epirubicin—sarcoma	0.000399	0.000552	CcSEcCtD
Sitaxentan—Visual impairment—Doxorubicin—sarcoma	0.000395	0.000546	CcSEcCtD
Sitaxentan—Alopecia—Epirubicin—sarcoma	0.000391	0.000541	CcSEcCtD
Sitaxentan—Mental disorder—Epirubicin—sarcoma	0.000388	0.000536	CcSEcCtD
Sitaxentan—Malnutrition—Epirubicin—sarcoma	0.000386	0.000533	CcSEcCtD
Sitaxentan—Diarrhoea—Etoposide—sarcoma	0.000384	0.000531	CcSEcCtD
Sitaxentan—Eye disorder—Doxorubicin—sarcoma	0.000383	0.000529	CcSEcCtD
Sitaxentan—Tinnitus—Doxorubicin—sarcoma	0.000382	0.000528	CcSEcCtD
Sitaxentan—Flushing—Doxorubicin—sarcoma	0.00038	0.000526	CcSEcCtD
Sitaxentan—Cardiac disorder—Doxorubicin—sarcoma	0.00038	0.000526	CcSEcCtD
Sitaxentan—Tension—Epirubicin—sarcoma	0.000378	0.000523	CcSEcCtD
Sitaxentan—Nervousness—Epirubicin—sarcoma	0.000374	0.000517	CcSEcCtD
Sitaxentan—Angiopathy—Doxorubicin—sarcoma	0.000372	0.000514	CcSEcCtD
Sitaxentan—Dizziness—Etoposide—sarcoma	0.000371	0.000513	CcSEcCtD
Sitaxentan—Muscle spasms—Epirubicin—sarcoma	0.000371	0.000512	CcSEcCtD
Sitaxentan—Immune system disorder—Doxorubicin—sarcoma	0.00037	0.000512	CcSEcCtD
Sitaxentan—Mediastinal disorder—Doxorubicin—sarcoma	0.000369	0.00051	CcSEcCtD
Sitaxentan—Alopecia—Doxorubicin—sarcoma	0.000362	0.0005	CcSEcCtD
Sitaxentan—Mental disorder—Doxorubicin—sarcoma	0.000359	0.000496	CcSEcCtD
Sitaxentan—Ill-defined disorder—Epirubicin—sarcoma	0.000358	0.000494	CcSEcCtD
Sitaxentan—Vomiting—Etoposide—sarcoma	0.000357	0.000493	CcSEcCtD
Sitaxentan—Malnutrition—Doxorubicin—sarcoma	0.000357	0.000493	CcSEcCtD
Sitaxentan—Anaemia—Epirubicin—sarcoma	0.000356	0.000492	CcSEcCtD
Sitaxentan—Agitation—Epirubicin—sarcoma	0.000354	0.00049	CcSEcCtD
Sitaxentan—Rash—Etoposide—sarcoma	0.000354	0.000489	CcSEcCtD
Sitaxentan—Dermatitis—Etoposide—sarcoma	0.000354	0.000489	CcSEcCtD
Sitaxentan—Headache—Etoposide—sarcoma	0.000352	0.000486	CcSEcCtD
Sitaxentan—Tension—Doxorubicin—sarcoma	0.00035	0.000484	CcSEcCtD
Sitaxentan—Malaise—Epirubicin—sarcoma	0.000348	0.00048	CcSEcCtD
Sitaxentan—Nervousness—Doxorubicin—sarcoma	0.000347	0.000479	CcSEcCtD
Sitaxentan—Vertigo—Epirubicin—sarcoma	0.000346	0.000479	CcSEcCtD
Sitaxentan—Leukopenia—Epirubicin—sarcoma	0.000345	0.000477	CcSEcCtD
Sitaxentan—Muscle spasms—Doxorubicin—sarcoma	0.000343	0.000474	CcSEcCtD
Sitaxentan—Nausea—Etoposide—sarcoma	0.000333	0.000461	CcSEcCtD
Sitaxentan—Ill-defined disorder—Doxorubicin—sarcoma	0.000331	0.000457	CcSEcCtD
Sitaxentan—Anaemia—Doxorubicin—sarcoma	0.00033	0.000456	CcSEcCtD
Sitaxentan—Chest pain—Epirubicin—sarcoma	0.000328	0.000454	CcSEcCtD
Sitaxentan—Agitation—Doxorubicin—sarcoma	0.000328	0.000453	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000326	0.00045	CcSEcCtD
Sitaxentan—Discomfort—Epirubicin—sarcoma	0.000324	0.000448	CcSEcCtD
Sitaxentan—Malaise—Doxorubicin—sarcoma	0.000322	0.000445	CcSEcCtD
Sitaxentan—Dry mouth—Epirubicin—sarcoma	0.000321	0.000444	CcSEcCtD
Sitaxentan—Vertigo—Doxorubicin—sarcoma	0.000321	0.000443	CcSEcCtD
Sitaxentan—Leukopenia—Doxorubicin—sarcoma	0.000319	0.000441	CcSEcCtD
Sitaxentan—Confusional state—Epirubicin—sarcoma	0.000317	0.000438	CcSEcCtD
Sitaxentan—Oedema—Epirubicin—sarcoma	0.000315	0.000435	CcSEcCtD
Sitaxentan—Infection—Epirubicin—sarcoma	0.000313	0.000432	CcSEcCtD
Sitaxentan—Nervous system disorder—Epirubicin—sarcoma	0.000309	0.000426	CcSEcCtD
Sitaxentan—Thrombocytopenia—Epirubicin—sarcoma	0.000308	0.000426	CcSEcCtD
Sitaxentan—Tachycardia—Epirubicin—sarcoma	0.000307	0.000424	CcSEcCtD
Sitaxentan—Skin disorder—Epirubicin—sarcoma	0.000306	0.000422	CcSEcCtD
Sitaxentan—Chest pain—Doxorubicin—sarcoma	0.000304	0.00042	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000302	0.000417	CcSEcCtD
Sitaxentan—Discomfort—Doxorubicin—sarcoma	0.0003	0.000415	CcSEcCtD
Sitaxentan—Anorexia—Epirubicin—sarcoma	0.0003	0.000414	CcSEcCtD
Sitaxentan—Dry mouth—Doxorubicin—sarcoma	0.000297	0.00041	CcSEcCtD
Sitaxentan—Hypotension—Epirubicin—sarcoma	0.000294	0.000406	CcSEcCtD
Sitaxentan—Confusional state—Doxorubicin—sarcoma	0.000294	0.000406	CcSEcCtD
Sitaxentan—Oedema—Doxorubicin—sarcoma	0.000291	0.000402	CcSEcCtD
Sitaxentan—Infection—Doxorubicin—sarcoma	0.000289	0.0004	CcSEcCtD
Sitaxentan—Nervous system disorder—Doxorubicin—sarcoma	0.000286	0.000395	CcSEcCtD
Sitaxentan—Thrombocytopenia—Doxorubicin—sarcoma	0.000285	0.000394	CcSEcCtD
Sitaxentan—Insomnia—Epirubicin—sarcoma	0.000285	0.000393	CcSEcCtD
Sitaxentan—Tachycardia—Doxorubicin—sarcoma	0.000284	0.000393	CcSEcCtD
Sitaxentan—Skin disorder—Doxorubicin—sarcoma	0.000283	0.000391	CcSEcCtD
Sitaxentan—Somnolence—Epirubicin—sarcoma	0.00028	0.000387	CcSEcCtD
Sitaxentan—Anorexia—Doxorubicin—sarcoma	0.000278	0.000384	CcSEcCtD
Sitaxentan—Dyspepsia—Epirubicin—sarcoma	0.000277	0.000383	CcSEcCtD
Sitaxentan—Decreased appetite—Epirubicin—sarcoma	0.000274	0.000378	CcSEcCtD
Sitaxentan—Hypotension—Doxorubicin—sarcoma	0.000272	0.000376	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Epirubicin—sarcoma	0.000272	0.000375	CcSEcCtD
Sitaxentan—Fatigue—Epirubicin—sarcoma	0.000271	0.000375	CcSEcCtD
Sitaxentan—Pain—Epirubicin—sarcoma	0.000269	0.000372	CcSEcCtD
Sitaxentan—Constipation—Epirubicin—sarcoma	0.000269	0.000372	CcSEcCtD
Sitaxentan—Insomnia—Doxorubicin—sarcoma	0.000263	0.000364	CcSEcCtD
Sitaxentan—Feeling abnormal—Epirubicin—sarcoma	0.000259	0.000358	CcSEcCtD
Sitaxentan—Somnolence—Doxorubicin—sarcoma	0.000259	0.000358	CcSEcCtD
Sitaxentan—Dyspepsia—Doxorubicin—sarcoma	0.000256	0.000354	CcSEcCtD
Sitaxentan—Decreased appetite—Doxorubicin—sarcoma	0.000253	0.00035	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000251	0.000347	CcSEcCtD
Sitaxentan—Fatigue—Doxorubicin—sarcoma	0.000251	0.000347	CcSEcCtD
Sitaxentan—Urticaria—Epirubicin—sarcoma	0.00025	0.000345	CcSEcCtD
Sitaxentan—Constipation—Doxorubicin—sarcoma	0.000249	0.000344	CcSEcCtD
Sitaxentan—Pain—Doxorubicin—sarcoma	0.000249	0.000344	CcSEcCtD
Sitaxentan—Body temperature increased—Epirubicin—sarcoma	0.000249	0.000344	CcSEcCtD
Sitaxentan—Feeling abnormal—Doxorubicin—sarcoma	0.00024	0.000332	CcSEcCtD
Sitaxentan—Hypersensitivity—Epirubicin—sarcoma	0.000232	0.00032	CcSEcCtD
Sitaxentan—Urticaria—Doxorubicin—sarcoma	0.000231	0.00032	CcSEcCtD
Sitaxentan—Body temperature increased—Doxorubicin—sarcoma	0.00023	0.000318	CcSEcCtD
Sitaxentan—Asthenia—Epirubicin—sarcoma	0.000226	0.000312	CcSEcCtD
Sitaxentan—Diarrhoea—Epirubicin—sarcoma	0.000215	0.000298	CcSEcCtD
Sitaxentan—Hypersensitivity—Doxorubicin—sarcoma	0.000215	0.000296	CcSEcCtD
Sitaxentan—Asthenia—Doxorubicin—sarcoma	0.000209	0.000289	CcSEcCtD
Sitaxentan—Dizziness—Epirubicin—sarcoma	0.000208	0.000288	CcSEcCtD
Sitaxentan—Vomiting—Epirubicin—sarcoma	0.0002	0.000276	CcSEcCtD
Sitaxentan—Diarrhoea—Doxorubicin—sarcoma	0.000199	0.000275	CcSEcCtD
Sitaxentan—Rash—Epirubicin—sarcoma	0.000198	0.000274	CcSEcCtD
Sitaxentan—Dermatitis—Epirubicin—sarcoma	0.000198	0.000274	CcSEcCtD
Sitaxentan—Headache—Epirubicin—sarcoma	0.000197	0.000272	CcSEcCtD
Sitaxentan—Dizziness—Doxorubicin—sarcoma	0.000193	0.000266	CcSEcCtD
Sitaxentan—Nausea—Epirubicin—sarcoma	0.000187	0.000258	CcSEcCtD
Sitaxentan—Vomiting—Doxorubicin—sarcoma	0.000185	0.000256	CcSEcCtD
Sitaxentan—Rash—Doxorubicin—sarcoma	0.000184	0.000254	CcSEcCtD
Sitaxentan—Dermatitis—Doxorubicin—sarcoma	0.000183	0.000253	CcSEcCtD
Sitaxentan—Headache—Doxorubicin—sarcoma	0.000182	0.000252	CcSEcCtD
Sitaxentan—Nausea—Doxorubicin—sarcoma	0.000173	0.000239	CcSEcCtD
